2-Bromo-1-(3,5-dichloro-2-methoxyphenyl)ethanone, 5g

1-[(4-Fluorophenyl)sulfonyl]-2-pyrrolidinecarboxylic acid, 95.0%, 10g

Sodium acetate, anhydrous, 99.0%, 100g

1,3,5-Tris[4-[bis(4-methoxyphenyl)amino]phenyl]benzene>95.0%(HPLC)1g

Ethyl 5-methoxy-1H-indazole-3-carboxylate, 98%, 1g

N-(4-aminophenyl)-4-methylbenzenesulfonamide, 1g

4,4'-IMINODIBENZOIC ACID, 95%, 25g

N,O-Bis(trimethylsilyl)trifluoroacetamide Kit BSTFA 1 mL * 8 / Reaction vial, capacity 2 mL * 81kit

4-Bromo-7-nitro-1H-indazole, 95.0%, 1g

4'-Fluoro-2'-methoxy-2,2,2-trifluoroacetophenone, 97.0%, 500mg

(S)-2-((tert-Butoxycarbonyl)amino)hex-5-enoic acid, 97%, 250mg

Sodium 2,2,3,3,3-pentafluoropropanoate, 98%, 100g

n,3-Dimethylpyrazin-2-amine, 98%, 1g